|
[Related PubMed/MEDLINE]
Total Number of Papers: 2180
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: FDG-PET |
| Long Form |
: fluorodeoxyglucose positron emission tomography |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
A case of lymphangioleiomyomatosis with diffuse large B-cell lymphoma: Usefulness of FDG-PET. |
LAM |
| 2 |
2020 |
A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis. |
BHL, IgG4-RD |
| 3 |
2020 |
A double-blind placebo-controlled clinical trial testing the effect of hyperbaric oxygen therapy on brain and cognitive outcomes of mildly cognitively impaired elderly with type 2 diabetes: Study design. |
ASL-MRI, CBF, HBOT, T2D |
| 4 |
2020 |
Abscopal Regressions of Lymphoma After Involved-Site Radiation Therapy Confirmed by Positron Emission Tomography. |
CMR, FL, ISRT |
| 5 |
2020 |
Alterations in the metabolic networks of temporal lobe epilepsy patients: A graph theoretical analysis using FDG-PET. |
HS, TLE |
| 6 |
2020 |
Alzheimer's deterioration in intellectual and neurobiological staging supports the retrogenesis model: a double dissociation between verbal/non-verbal judgments and the left/right parieto-temporal glucose metabolism. A retrospective data analysis from the Tajiri Project. |
AD, CMRglc |
| 7 |
2020 |
An application of generalized matrix learning vector quantization in neuroimaging. |
GMLVQ, PD, SSM/PCA |
| 8 |
2020 |
Associations Between FDG PET and Expression of VEGF and Microvessel Density in Different Solid Tumors: A Meta-analysis. |
CI, MVD, VEGF |
| 9 |
2020 |
Bipolar Disorder Among Patients Diagnosed With Frontotemporal Dementia. |
bvFTD |
| 10 |
2020 |
Brain 18F-FDG-PET: Utility in the Diagnosis of Dementia and Epilepsy. |
--- |
| 11 |
2020 |
Brain activity underlying American crow processing of encounters with dead conspecifics. |
--- |
| 12 |
2020 |
Clinical symptoms and associated vascular imaging findings in Takayasu's arteritis compared to giant cell arteritis. |
GCA, MRA, TAK |
| 13 |
2020 |
Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy. |
ADL, MMSE, MRI, PSP, UPDRS |
| 14 |
2020 |
Combined tumor plus nontumor interim FDG-PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancer. |
CRT, EFS, ESCC, FFDM, LRC, OS |
| 15 |
2020 |
Continuous infusion chemotherapy, radiotherapy, and FDG-PET are feasible during extracorporeal membrane oxygenation. |
ECMO |
| 16 |
2020 |
Current Progress on Assessing the Prognosis for Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis. |
EEG, MRI, NMDAR |
| 17 |
2020 |
Dependence of fluorodeoxyglucose (FDG) uptake on cell cycle and dry mass: a single-cell study using a multi-modal radiography platform. |
FDG, PI |
| 18 |
2020 |
Diagnostic Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Gastric Mesenchymal Tumors. |
FDG, GISTs |
| 19 |
2020 |
Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation Therapy. |
CLI, FFP, FL, TNI, WFRT |
| 20 |
2020 |
Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis. |
GCA, LVV, TA |
| 21 |
2020 |
Evaluating Positron Emission Tomography-Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients With Lung Cancer. |
OS |
| 22 |
2020 |
Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal Adenocarcinoma. |
NA, OS, PDAC |
| 23 |
2020 |
Evidence and Considerations on Treatment of Small Size Merkel Cell Head and Neck Carcinoma. |
CT, SLNs |
| 24 |
2020 |
Expression of Cellular Receptors in the Ischemic Hemisphere of Mice with Increased Glucose Uptake. |
UCCAO |
| 25 |
2020 |
FDG-PET assessment and metabolic patterns in Lafora disease. |
LD |
| 26 |
2020 |
FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis. |
CRLM, GLUT1, HIF-1alpha, PKM2, SUV |
| 27 |
2020 |
Feasibility of Assessing Inflammation in Asymptomatic Abdominal Aortic Aneurysms With Integrated 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging. |
AAA, LGE, MRI, SUV |
| 28 |
2020 |
Features and clinical impact of extra-cardiac lesions with 18F-fluorodeoxyglucose positron emission tomography in patients with suspected cardiac sarcoidosis. |
EMB |
| 29 |
2020 |
Focal cortical dysplasia imaging discrepancies between MRI and FDG-PET: Unique association with temporal lobe location. |
FCD, MRI |
| 30 |
2020 |
Genomic Signature of the Standardized Uptake Value in 18F-Fluorodeoxyglucose Positron Emission Tomography in Breast Cancer. |
BRC, CI, HR, SUV |
| 31 |
2020 |
Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype. |
DOI, GLUT1, HIF1a, OSCC |
| 32 |
2020 |
Identification of a Pathogenic PSEN1 Ala285Val Mutation Associated with Early-Onset Alzheimer's Disease. |
AD, FBB-PET, PSEN1 |
| 33 |
2020 |
Imaging in Suspected Cardiac Sarcoidosis: A Diagnostic Challenge. |
CMR, CS, LV, TTE |
| 34 |
2020 |
In-vivo signatures of neurodegeneration in isolated rapid eye movement sleep behaviour disorder. |
iRBD |
| 35 |
2020 |
Influence of Hypertension on Longitudinal Changes in Brain Glucose Metabolism Was Modified by the APOE4 Allele Among Cognitively Normal Older Individuals. |
ADNI, APOE4, HTN |
| 36 |
2020 |
Integrated strategy combining endobronchial ultrasound with positron emission tomography to diagnose peripheral pulmonary lesions. |
EBUS-TBLB, PPLs |
| 37 |
2020 |
Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease. |
AD, CR |
| 38 |
2020 |
Intranasal anti-caspase-1 therapy preserves myelin and glucose metabolism in a model of progressive multiple sclerosis. |
BMCs, CNS, MS, NAWM |
| 39 |
2020 |
Is Paget Disease of Bone more Common in South India? Clinical Characteristics, Therapeutic Outcome and follow-up of 66 Patients from Tamil Nadu. |
PDB, SAP |
| 40 |
2020 |
Is there any correlation between HPV and early radioresponse before brachytherapy in cervix uteri carcinoma? |
HPV, MRI |
| 41 |
2020 |
Liver metastasis from papillary thyroid carcinoma treated by laparoscopic hepatectomy 43 years after resection of the primary tumor: a case report. |
PTC |
| 42 |
2020 |
Management of FDG avid Benign Sinonasal Schneiderian Papilloma: A Case Report and Review of the Literature. |
CT, MRI |
| 43 |
2020 |
Maturation of topological organization of brain networks in male adolescent rats: A longitudinal FDG-PET study. |
--- |
| 44 |
2020 |
Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography. |
AD, CN, DLB |
| 45 |
2020 |
MRI and FDG PET/CT Findings for Borderline Brenner Tumor of the Ovary: A Case Report and Literature Review. |
ADC, BT, DWI, MRI, SI, T2WI |
| 46 |
2020 |
Multi-modal neuroimaging feature selection with consistent metric constraint for diagnosis of Alzheimer's disease. |
AD, ADNI, AUC, MCI, MCI-C, MCI-NC, MK-SVM, NC, VBM-MRI |
| 47 |
2020 |
Multimodal neurometabolic investigation of the effects of zolpidem on leukoencephalopathy-related apathy. |
GABA, MRS |
| 48 |
2020 |
Neural correlates of different behavioral response to transcranial direct current stimulation between patients in the unresponsive wakefulness syndrome and minimally conscious state. |
CMRgl, CRS-R, DLPFC, ERP, MCS, tDCS, UWS |
| 49 |
2020 |
Nociception Coma Scale-Revised Allows to Identify Patients With Preserved Neural Basis for Pain Experience. |
DOC, NCS-R, UWS |
| 50 |
2020 |
Novel Antineuronal Autoantibodies With Somatodendritic Staining Pattern in a Patient With Autoimmune Psychosis. |
CSF, EEG, MRI |
| 51 |
2020 |
Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderly. |
AD, BMI, CSF, FWE |
| 52 |
2020 |
Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders. |
AD, MRI |
| 53 |
2020 |
Parkinson Disease-Related Pattern of Glucose Metabolism Associated With the Potential for Motor Improvement After Deep Brain Stimulation. |
DBS, PD, SUVRs |
| 54 |
2020 |
Parkinsonian Syndrome with Frontal Lobe Involvement and Anti-Glycine Receptor Antibodies. |
anti-GlyR, CBD, CSF, MRI, PSP, SPECT |
| 55 |
2020 |
Pathogenic PSEN1 Thr119Ile Mutation in Two Korean Patients with Early-Onset Alzheimer's Disease. |
AD, EOAD, MRI, PET, PSEN1 |
| 56 |
2020 |
PD-1/PD-L1 negative schwannoma mimicking obstructive bronchial malignancy: A case report. |
--- |
| 57 |
2020 |
Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer. |
MTD |
| 58 |
2020 |
Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC). |
CT, MIBC, MRI |
| 59 |
2020 |
Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment. |
BM, BMI, CK, DLBCL, HSCT, IPI |
| 60 |
2020 |
Positron Emission Tomography for Response Evaluation in Microenvironment-Targeted Anti-Cancer Therapy. |
--- |
| 61 |
2020 |
Posterior Cingulate Cortex Hypometabolism in Non-Amnestic Variants of Alzheimer's Disease. |
AD, FTD, PCC, ROI |
| 62 |
2020 |
Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study. |
AD, ADAS-cog, ADNI, AUC, BNA, MCI, MMSE, pMCI, RBF, sMCI, SVM |
| 63 |
2020 |
Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning. |
AD, MRI |
| 64 |
2020 |
Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy. |
CI, ESCC, HR, LI, nCRT |
| 65 |
2020 |
Predictive value of suvmax changes between two sequential post-therapeutic FDG-pet in head and neck squamous cell carcinomas. |
CT, MRI |
| 66 |
2020 |
Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX. |
BR, CA19-9, LA |
| 67 |
2020 |
Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial. |
5-PS, CI, EOT, HR, iPET, OS, PFS |
| 68 |
2020 |
Psychiatric Manifestation of Anti-LGI1 Encephalitis. |
LGI1 |
| 69 |
2020 |
Quantifying brain metabolism from FDG-PET images into a probability of Alzheimer's dementia score. |
AD, SDAT |
| 70 |
2020 |
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics. |
CT, LPA |
| 71 |
2020 |
Reevaluation of Astrocyte-Neuron Energy Metabolism with Astrocyte Volume Fraction Correction: Impact on Cellular Glucose Oxidation Rates, Glutamate-Glutamine Cycle Energetics, Glycogen Levels and Utilization Rates vs. Exercising Muscle, and Na+/K+ Pumping Rates. |
MRS |
| 72 |
2020 |
Retrograde amnesia with transposition in the past: A neuropsychological and PET study of a case. |
RA, SMS |
| 73 |
2020 |
Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any? |
GLM |
| 74 |
2020 |
Role of FDG-PET/CT in children with fever of unknown origin. |
CT, FUO |
| 75 |
2020 |
Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients. |
AD, OAA |
| 76 |
2020 |
Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer. |
AUC, MTV, RMSE, SUV |
| 77 |
2020 |
Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer. |
CT |
| 78 |
2020 |
Speckle tracking echocardiography can predict subclinical myocardial involvement in patients with sarcoidosis: A meta-analysis. |
CI, CMR, CS, GCS, LV-GLS, MCE, SMD, STE |
| 79 |
2020 |
Team Approach: Evaluation and Management of Low-Grade Cartilaginous Lesions. |
CT, MRI |
| 80 |
2020 |
The PET Sandwich: Using Serial FDG-PET Scans with Interval Burst Suppression to Assess Ictal Components of Disease. |
cvEEG, IIC |
| 81 |
2020 |
The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population. |
CT |
| 82 |
2020 |
Three cases of follicular pancreatitis: association between radiological findings and pathological features. |
FP, SUV |
| 83 |
2020 |
Timing of fluorodeoxyglucose positron emission tomography maximum standardized uptake value for diagnosis of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy. |
NSCLC, PFS, SBRT |
| 84 |
2020 |
Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma. |
CytAct, ICB, LUAD |
| 85 |
2020 |
Tumor Segmentation and Feature Extraction from Whole-Body FDG-PET/CT Using Cascaded 2D and 3D Convolutional Neural Networks. |
NHL, NSCLC |
| 86 |
2020 |
Value of SUVmax for the Prediction of Bone Invasion in Oral Squamous Cell Carcinoma. |
OSCC |
| 87 |
2020 |
Variability of clinical syndromes and cerebral glucose metabolism in symptomatic frontotemporal lobar degeneration associated with progranulin mutations. |
--- |
| 88 |
2020 |
Well-differentiated fetal adenocarcinoma of the lung: positron emission tomography features and diagnostic difficulties in frozen section analysis-a case report. |
WDFA |
| 89 |
2020 |
What Are the Results of Resection of Localized Dedifferentiated Liposarcomas in the Extremities? |
ALT, CDK4, DDLPS, PET/CT |
| 90 |
2020 |
[18F-fluorodeoxyglucose-positron emission tomography imaging before and after treatment of chronic-phase chronic myeloid leukemia with tyrosine kinase inhibitors]. |
CML |
| 91 |
2020 |
[Metachronous Pubic Bone Metastases from Synchronous Double Cancer with Prostate and Ascending Colon Cancers : A Case Report]. |
CA19-9, CEA, PSA |
| 92 |
2019 |
18F-FDG-PET in Finnish patients with clinical suspicion of cardiac sarcoidosis: Female sex and history of atrioventricular block increase the prevalence of positive PET findings. |
CS |
| 93 |
2019 |
18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Treatment Efficacy and Clinical Outcome for Patients With Pancreatic Carcinoma: A Meta-analysis. |
HR |
| 94 |
2019 |
A Nude Mouse Model of Orthotopic Liver Transplantation of Human Hepatocellular Carcinoma HCCLM3 Cell Xenografts and the Use of Imaging to Evaluate Tumor Progression. |
alpha-SMA, CEUS, HCC, US, VEGF |
| 95 |
2019 |
Anti-N-methyl-D-aspartate Encephalitis Concomitantly with Tall-cell Variant Papillary Thyroid Carcinoma. |
NMDA |
| 96 |
2019 |
Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance. |
HC, SNT |
| 97 |
2019 |
Association of metabolic and genetic heterogeneity in head and neck squamous cell carcinoma with prognostic implications: integration of FDG PET and genomic analysis. |
GlycoS, HNSC, MATH |
| 98 |
2019 |
Associations between GLUT expression and SUV values derived from FDG-PET in different tumors-A systematic review and meta analysis. |
GLUT, SUV |
| 99 |
2019 |
Brain metabolic connectome classify mild cognitive impairment into Alzheimer's dementia. |
AD, MCI |
| 100 |
2019 |
Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma. |
cHL, HSCT, PFS, R/R |
|
A Search Service for Abbreviation / Long Form
